-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
ELITE PHARMACEUTICALS INC /NV/ quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and change rate from Q4 2021 to Q4 2023.
- ELITE PHARMACEUTICALS INC /NV/ Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 31 Dec 2023 was $18,870, a 27.2% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)